Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy
- 1.2k Downloads
Two-stage hepatectomy (TSH) is well established for the treatment of patients who have colorectal cancer liver metastases (CRLM) with a small liver remnant. The technique of associating liver partitioning and portal vein occlusion for staged hepatectomy (ALPPS) has been advocated as a novel tool to increase resectability. Using a case-match design, this study aimed to compare TSH and ALPPS for patients with CRLM.
All patients undergoing ALPPS for CRLM at three major hepatobiliary centers in Italy (ALPPS group) were compared in a case-match analysis with patients undergoing TSH (TSH group) at a single institution. The groups were matched with a 1:3 ratio using propensity scores based on covariates representing severity of metastatic disease. The main end points of the study were feasibility of complete resection and intra- and postoperative outcomes.
The two treatments did not differ significantly in feasibility. Two patients in the TSH group dropped out compared with no patients in the ALPPS group. A comparable volume gain in future liver remnant (FLR) was obtained in the ALPPS and TSH groups (47 vs. 41 %, nonsignificant difference) but during a shorter interval in ALPPS group. The overall and major complication rate was significantly higher after stage 2 in the ALPPS group (Clavien ≥ 3a: 41.7 vs. 17.6 % in TSH group; p = 0.025).
The feasibility of resection using ALPPS compared with TSH for CRLM was not significantly greater, but perioperative complications were increased. Therefore, ALPPS should be proposed to patients with caution and warnings. Currently, TSH remains the standard approach for performing R0 resection in patients with advanced CRLM and inadequate FLR.
KeywordsPropensity Score Colorectal Liver Metastasis Portal Vein Embolization Future Liver Remnant Middle Hepatic Vein
There are no conflicts of interest to disclose.
- 5.Giuliante F, Ardito F, Ferrero A, et al. Tumor progression during preoperative chemotherapy predicts failure to complete two-stage hepatectomy for colorectal liver metastases: results of an Italian multicenter analysis of 130 patients. J Am Coll Surg. 2014;219:285–94.Google Scholar
- 6.Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1,001 consecutive cases. Ann Surg. 1999;230:309–18; discussion 318–21.Google Scholar
- 10.Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple an bilobar liver metastases. Ann Surg. 2004;240:1037–49.CrossRefPubMedCentralPubMedGoogle Scholar
- 12.Schnitzbauer AA, Lang SA, Goessmann et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small for size settings. Ann Surg. 2012;255:405–14.Google Scholar
- 13.Schadde E, Ardiles V, Robles-Campos R et al. on behalf of the ALPPS Registry Group. Early survival and safety of ALPPS: First Report of the International ALPPS Registry. Ann Surg. 2014;260:829–38.Google Scholar
- 18.Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6,336 patients and results of a survey. Ann Surg. 2004;240:205–13.Google Scholar
- 21.Mosteller RD. Simplified calculation of body surface area. N Eng J Med. 1987;317:1098.Google Scholar
- 23.Schadde E, Schnitzbauer A, Tschuor C, Raptis D, Bechstein W, Clavien PA. Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Ann Surg Oncol. 2014. doi: 10.1245/s10434-014-4213-5.
- 25.Shindoh J, Vauthey JN, Zimmitti G, et al. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy. J Am Coll Surg. 2013;217:126–33.CrossRefPubMedGoogle Scholar
- 33.Li J, Kantas A, Ittrich H, et al. Avoid “all-touch” by hybrid ALPPS to achieve oncological efficacy. Ann Surg. 2014. doi: 10.1097/SLA.0000000000000845.